Analytica Limited (ASX:ALT) is heading to market with a capital raising.
The ASX has granted the company a trading halt, with its shares placed in pre-open.
Analytica’s lead product is the PeriCoach™ System – an e-health treatment system for women who suffer Stress Urinary Incontinence.
PeriCoach™ comprises a device, web portal and smartphone app. The device evaluates activity in pelvic floor muscles. This information is transmitted to a smartphone app and can be loaded to PeriCloud where physicians can monitor patient progress via web portal.
The U.S. market for incontinence pads is $5 billion annually.
In Australia, it has been projected that by 2030, 5.6 million women in Australia will suffer urinary incontinence.
The halt will remain in place until the opening of trade on Wednesday 1 October 2014, or earlier if an announcement is made to the market.
Add to My Watchlist
What is My Watchlist?